| الوصف: |
Thomas Chester,1 Sumit (Sam) Garg,2 Josh Johnston,3,4 Brandon Ayers,5 Preeya Gupta6,7 1Cleveland Eye Clinic, Brecksville, OH, USA; 2Department of Ophthalmology, Gavin Herbert Eye Institute, University of California-Irvine, Irvine, CA, USA; 3Georgia Eye Partners, Atlanta, GA, USA; 4Southern College of Optometry, Memphis, TN, USA; 5Ophthalmic Partners PC, Cornea Service, Wills Eye Hospital, Philadelphia, PA, USA; 6Triangle Eye Consultants, Raleigh, NC, USA; 7Department of Ophthalmology, Tulane University, New Orleans, LA, USACorrespondence: Thomas Chester, 7001 S. Edgerton Rd, Brecksville, OH, 44141, USA, Tel +1 440 526 1974, Fax +1 440 526 2352, Email drchester@clevelandeyeclinic.comAbstract: Dry eye disease (DED) is a common ocular condition, but the diagnosis relative to other ocular conditions and the evaluation of severity of the condition has often been difficult. This challenge can be due to clinical signs and symptoms not always correlating with each other. An understanding of the various components which create the condition, as well as the diagnostic measures used to evaluate these components, is useful to the clinician working with DED patients. This review paper will discuss traditional diagnostic options, diagnostic imaging, and Advanced Point of Care testing capabilities to determine the severity level of dry eye disease more adequately.Keywords: dry eye disease, diagnostic imaging, POC testing, biomarkers |
Full Text Finder